172 related articles for article (PubMed ID: 20158286)
1. Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios.
Johansson S; Wallander MA; de Abajo FJ; García Rodríguez LA
Drug Saf; 2010 Mar; 33(3):223-32. PubMed ID: 20158286
[TBL] [Abstract][Full Text] [Related]
2. Identifying major congenital malformations in the UK General Practice Research Database (GPRD): a study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD.
Charlton RA; Weil JG; Cunnington MC; de Vries CS
Drug Saf; 2010 Sep; 33(9):741-50. PubMed ID: 20701407
[TBL] [Abstract][Full Text] [Related]
3. Identification and evaluation of a possible signal of exacerbation of colitis during rofecoxib treatment, using Prescription-Event Monitoring data.
Layton D; Heeley E; Shakir SA
J Clin Pharm Ther; 2004 Apr; 29(2):171-81. PubMed ID: 15068407
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Methods for retrospective detection of drug safety signals and adverse events in electronic general practice records.
Tomlin A; Reith D; Dovey S; Tilyard M
Drug Saf; 2012 Sep; 35(9):733-43. PubMed ID: 22861670
[TBL] [Abstract][Full Text] [Related]
6. The general practice research database: role in pharmacovigilance.
Wood L; Martinez C
Drug Saf; 2004; 27(12):871-81. PubMed ID: 15366975
[TBL] [Abstract][Full Text] [Related]
7. Signal Detection for Recently Approved Products: Adapting and Evaluating Self-Controlled Case Series Method Using a US Claims and UK Electronic Medical Records Database.
Zhou X; Douglas IJ; Shen R; Bate A
Drug Saf; 2018 May; 41(5):523-536. PubMed ID: 29327136
[TBL] [Abstract][Full Text] [Related]
8. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
9. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
[TBL] [Abstract][Full Text] [Related]
10. Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries.
Charlton RA; Cunnington MC; de Vries CS; Weil JG
Drug Saf; 2008; 31(1):39-51. PubMed ID: 18095745
[TBL] [Abstract][Full Text] [Related]
11. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
Trifirò G; Coloma PM; Rijnbeek PR; Romio S; Mosseveld B; Weibel D; Bonhoeffer J; Schuemie M; van der Lei J; Sturkenboom M
J Intern Med; 2014 Jun; 275(6):551-61. PubMed ID: 24635221
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.
Zhou X; Murugesan S; Bhullar H; Liu Q; Cai B; Wentworth C; Bate A
Drug Saf; 2013 Feb; 36(2):119-34. PubMed ID: 23329543
[TBL] [Abstract][Full Text] [Related]
13. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid.
García Rodríguez LA; Stricker BH; Zimmerman HJ
Arch Intern Med; 1996 Jun; 156(12):1327-32. PubMed ID: 8651842
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Potential Routine Use of Electronic Healthcare Record Data to Strengthen Early Signal Assessment in UK Medicines Regulation: Proof-of-Concept Study.
Donegan K; Owen R; Bird H; Burch B; Smith A; Tregunno P
Drug Saf; 2018 Sep; 41(9):899-910. PubMed ID: 29725942
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
16. Automated safety event monitoring using electronic medical records in a clinical trial setting: Validation study using the VA NEPHRON-D trial.
Huang Y; Fried LF; Kyriakides TC; Johnson GR; Chiu S; Mcdonald L; Zhang JH
Clin Trials; 2019 Feb; 16(1):81-89. PubMed ID: 30445841
[TBL] [Abstract][Full Text] [Related]
17. Use of the UK General Practice Research Database for pharmacoepidemiology.
García Rodríguez LA; Pérez Gutthann S
Br J Clin Pharmacol; 1998 May; 45(5):419-25. PubMed ID: 9643612
[TBL] [Abstract][Full Text] [Related]
18. The London low emission zone baseline study.
Kelly F; Armstrong B; Atkinson R; Anderson HR; Barratt B; Beevers S; Cook D; Green D; Derwent D; Mudway I; Wilkinson P;
Res Rep Health Eff Inst; 2011 Nov; (163):3-79. PubMed ID: 22315924
[TBL] [Abstract][Full Text] [Related]
19. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
[TBL] [Abstract][Full Text] [Related]
20. Review of the Methods to Obtain Paediatric Drug Safety Information: Spontaneous Reporting and Healthcare Databases, Active Surveillance Programmes, Systematic Reviews and Meta-analyses.
Gentili M; Pozzi M; Peeters G; Radice S; Carnovale C
Curr Clin Pharmacol; 2018; 13(1):28-39. PubMed ID: 29412117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
